Post by
seanj1 on Jul 16, 2021 9:59am
Transition
Well not a pretty picture as far as sp is concerned. But I agree that B2C model was not going to get the company anywhere since most major companies have developed their own in house extraction facilities. If not sure just look at Medipharm stock. I like the transition model, Sprout was a great buy and that alone will give a nice boost to revenues going forward. As I said before Cannabis business in Canada will not be that profitable at least not for a while. The CBD in household products will be a major boost and I think that is coming. Nutraceutical and medical branches can be game changers . I am happy to hear that Transition phase has been completed and company does not plan to issue any more shares. Cash balance is in a good position as well. I also don't think that institutional investors are stupid to stay with the company at almost a record share count if they didn't expect good things to come.
Comment by
Sopranos1 on Jul 16, 2021 10:21am
Seanj1, I agree, but i am worried about a r/s down the road...they need to pull this back up over a dollar usd, soon..10 days + they will receive non compliance from Nasdaq, which dip this even more...
Comment by
seanj1 on Jul 16, 2021 10:25am
Not a fan of RS either, but even if it that happens they still have 180 days to get it back above $1..
Comment by
Sopranos1 on Jul 16, 2021 11:02am
Correct Seanj1.. Actually 2 x 180 days..if they have legit issue, nasdaq can grant a second 180. cross fingers..hopefully a nice pr of a deal in the US or something in the meantime to move sp.
Comment by
Sopranos1 on Jul 21, 2021 12:15pm
Several pumpers here, but that is ok, they have really no impact on sp, but when you have 3 brokerage houses go from a buy to a hold, that is concerning to the normal folks..pumpers and followers of them can think otherwise..I personally hope this gets back up to the mid 1's usd to get out of this pos